Distributor ignores FDA warning over anti-inflammatory drug in supplement
The U.S. Food and Drug Administration in April 2023 issued a public notification, recommending consumers not use a specific product marketed as a dietary supplement and sold for arthritis or joint pain. An FDA lab analysis verified the product called AK …